Shanghai Fosun Pharmaceutical (Group) Co. has made a non-binding proposal to buy India's Gland Pharma, which is backed by global private equity giant KKR, the Chinese firm said in a disclosure filing. The deal, which is still in early stage and has not been agreed to by Gland Pharma, could be valued at up to […]
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.
Visit the original source and full text: China Money Network